These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32813897)

  • 1. The profile of urinary biomarkers in overactive bladder.
    Rada MP; Ciortea R; Măluţan AM; Doumouchtsis SK; Bucuri CE; Clim A; Roman A; Mihu D
    Neurourol Urodyn; 2020 Nov; 39(8):2305-2313. PubMed ID: 32813897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary brain-derived neurotrophic factor: a potential biomarker for objective diagnosis of overactive bladder.
    Wang LW; Han XM; Chen CH; Ma Y; Hai B
    Int Urol Nephrol; 2014 Feb; 46(2):341-7. PubMed ID: 23982767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve Growth Factor and Brain-Derived Neurotrophic Factor as Potential Biomarkers of Mirabegron Efficacy in Patients with Overactive Bladder Syndrome.
    Beta A; Giannouli A; Rizos D; Mantzou A; Deligeoroglou E; Bakas P
    Int Urogynecol J; 2024 Jun; 35(6):1317-1322. PubMed ID: 38761233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary neurotrophic peptides in postmenopausal women with and without overactive bladder.
    Pennycuff JF; Schutte SC; Hudson CO; Karp DR; Malykhina AP; Northington GM
    Neurourol Urodyn; 2017 Mar; 36(3):740-744. PubMed ID: 27062604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of biomarkers in the diagnosis and treatment of overactive bladder: Can we predict the patients who will be resistant to treatment?
    Alkis O; Zumrutbas AE; Toktas C; Aybek H; Aybek Z
    Neurourol Urodyn; 2017 Feb; 36(2):390-393. PubMed ID: 26661444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel biomarkers of overactive bladder syndrome.
    Wróbel AF; Kluz T; Surkont G; Wlaźlak E; Skorupski P; Filipczak A; Rechberger T
    Ginekol Pol; 2017; 88(10):568-573. PubMed ID: 29192418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary Neurotrophin Levels Increase in Women With Stress Urinary Incontinence After a Midurethral Sling Procedure.
    Antunes-Lopes T; Coelho A; Pinto R; Barros SC; Cruz CD; Cruz F; Silva CM
    Urology; 2017 Jan; 99():49-56. PubMed ID: 27697460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary brain-derived neurotrophic factor and nerve growth factor as noninvasive biomarkers of overactive bladder in children.
    Colic M; Rogic D; Lenicek Krleza J; Kozmar A; Stemberger Maric L; Abdovic S
    Biochem Med (Zagreb); 2022 Oct; 32(3):030706. PubMed ID: 36277428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sensitivity and specificity of urinary and serum neurotrophins in the diagnosis of neurogenic detrusor overactivity in multiple sclerosis].
    Bazhenov IV; Filippova ES; Bazarnyi VV; Sazonov SV; Volkova LI; Zaitseva LN
    Urologiia; 2018 Jul; (3):44-48. PubMed ID: 30035417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary ATP may be a dynamic biomarker of detrusor overactivity in women with overactive bladder syndrome.
    Silva-Ramos M; Silva I; Oliveira O; Ferreira S; Reis MJ; Oliveira JC; Correia-de-Sá P
    PLoS One; 2013; 8(5):e64696. PubMed ID: 23741373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)?
    Seth JH; Sahai A; Khan MS; van der Aa F; de Ridder D; Panicker JN; Dasgupta P; Fowler CJ
    BJU Int; 2013 Mar; 111(3):372-80. PubMed ID: 23444927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of urinary biomarkers in the diagnosis of overactive bladder in female patients. A systematic review and meta-analysis.
    Tsiapakidou S; Apostolidis A; Pantazis K; Grimbizis GF; Mikos T
    Int Urogynecol J; 2021 Dec; 32(12):3143-3155. PubMed ID: 34363496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment.
    Liu HT; Kuo HC
    Urology; 2008 Jul; 72(1):104-8; discussion 108. PubMed ID: 18400272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary Nerve Growth Factor Can Predict Therapeutic Efficacy in Children With Overactive Bladder.
    Fukui S; Aoki K; Morizawa Y; Miyake M; Fujimoto K
    Urology; 2017 May; 103():214-217. PubMed ID: 28161379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder.
    Yokoyama T; Kumon H; Nagai A
    Neurourol Urodyn; 2008; 27(5):417-20. PubMed ID: 17924444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary neurotrophic factors in healthy individuals and patients with overactive bladder.
    Antunes-Lopes T; Pinto R; Barros SC; Botelho F; Silva CM; Cruz CD; Cruz F
    J Urol; 2013 Jan; 189(1):359-65. PubMed ID: 23174241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NGF and HB-EGF: potential biomarkers that reflect the effects of fesoterodine in patients with overactive bladder syndrome.
    Kim SR; Moon YJ; Kim SK; Bai SW
    Yonsei Med J; 2015 Jan; 56(1):204-11. PubMed ID: 25510766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Urinary Nerve Growth Factor and Brain-Derived Neurotrophic Factor be used in the Diagnosis and Follow-Up of Voiding Dysfunction in Children?
    Özdemir K; Dinçel N; Berdeli A; Mir S
    Urol J; 2016 Jun; 13(3):2690-6. PubMed ID: 27351324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could urinary nerve growth factor be a biomarker for overactive bladder? A meta-analysis.
    Sheng W; Zhang H; Ruth KH
    Neurourol Urodyn; 2017 Sep; 36(7):1703-1710. PubMed ID: 28102552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers in overactive bladder.
    Bhide AA; Cartwright R; Khullar V; Digesu GA
    Int Urogynecol J; 2013 Jul; 24(7):1065-72. PubMed ID: 23314226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.